Mankind Pharma Limited has informed the Exchange regarding Cessation of Mr Prateek Dubey as SMP of the company w.e.f. Jun 08, 2026.
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mankind Pharma has informed the stock exchange that Mr. Prateek Dubey has ceased to be a Senior Managerial Personnel (SMP) of the company, effective June 8, 2026. No reasons for the cessation have been disclosed in this filing. Mr. Dubey was not a director on the board but held a senior managerial role within the company. The company has not yet announced his replacement or successor in this filing.
This is a routine senior management exit with no immediate material impact on shareholders. Investors should watch for any follow-up filings disclosing the reason for departure and whether a replacement is announced, as frequent senior exits can signal internal instability.